Alexander Hardy

Alexander Hardy

President and CEOatBiomarin Pharmaceutical· In proxies 2023–2025

Pay in FY2025+48% from the year before · Biomarin Pharmaceutical stock -9.6% the same year

Alexander Hardy was paid $21.9M in FY2025 (Dec), up 48%. Biomarin Pharmaceutical stock fell 9.6% that year.

Pay$100 in the stock at the end of FY22 → $57
Pay is from the Summary Compensation Table of each Biomarin Pharmaceutical proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Biomarin PharmaceuticalPublic company · 3 yr
    • President and CEO2023 – Present · 3 yrStock in role -45%
  2. Manufacturers of AmericaPublic company
    • Director? – PresentNo stock prices for these years
  3. Pharmaceutical ResearchPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?